These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31464547)

  • 21. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
    Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal and Olfactory Deposition with Normal and Bidirectional Intranasal Delivery Techniques: In Vitro Tests and Numerical Simulations.
    Xi J; Wang Z; Nevorski D; White T; Zhou Y
    J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):118-131. PubMed ID: 27977306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy.
    Golshahi L; Longest PW; Azimi M; Syed A; Hindle M
    Respir Care; 2014 Oct; 59(10):1476-86. PubMed ID: 24917454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
    Cheng YS; Fu CS; Yazzie D; Zhou Y
    J Aerosol Med; 2001; 14(2):255-66. PubMed ID: 11681657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of regional nasal drug delivery using multiple anatomical nasal replicas of adult human subjects and two nasal sprays.
    Manniello MD; Hosseini S; Alfaifi A; Esmaeili AR; Kolanjiyil AV; Walenga R; Babiskin A; Sandell D; Mohammadi R; Schuman T; Hindle M; Golshahi L
    Int J Pharm; 2021 Jan; 593():120103. PubMed ID: 33242586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anatomically-detailed segmented representative adult and pediatric nasal models for assessing regional drug delivery and bioequivalence with suspension nasal sprays.
    Khadka P; Hejazi M; Hindle M; Schuman T; Longest W; Kaviratna A; Chopski S; Walenga R; Newman B; Golshahi L
    Int J Pharm; 2024 Dec; 666():124743. PubMed ID: 39343330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Simplified Geometric Model to Predict Nasal Spray Deposition in Children and Adults.
    Foo MY; Sawant N; Overholtzer E; Donovan MD
    AAPS PharmSciTech; 2018 Oct; 19(7):2767-2777. PubMed ID: 29948982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OTC fluticasone furoate nasal spray (Flonase Sensimist) for allergic rhinitis.
    Med Lett Drugs Ther; 2017 Apr; 59(1519):e70-e71. PubMed ID: 28419077
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate.
    Molet SM; Hamid QA; Hamilos DL
    Laryngoscope; 2003 Oct; 113(10):1803-12. PubMed ID: 14520110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro Comparison of Local Nasal Vaccine Delivery and Correlation with Device Spray Performance.
    Li L; Wilkins JV; Esmaeili AR; Rahman N; Golshahi L
    Pharm Res; 2023 Feb; 40(2):537-550. PubMed ID: 36536098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal Filtration of Inhaled Aerosol in Human Subjects as a Function of Nasal Pressure Drop.
    Golshahi L; Hosseini S
    J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):13-23. PubMed ID: 30199315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery.
    Neubauer PD; Schwam ZG; Manes RP
    Int Forum Allergy Rhinol; 2016 Mar; 6(3):233-7. PubMed ID: 26679480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):370-8. PubMed ID: 9357385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing quantitative relationships between changes in nasal spray in vitro metrics and drug delivery to the posterior nasal region.
    Kolanjiyil AV; Walenga R; Babiskin A; Golshahi L; Hindle M; Longest W
    Int J Pharm; 2023 Mar; 635():122718. PubMed ID: 36781083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis.
    Mak KK; Ku MS; Lu KH; Sun HL; Lue KH
    Pediatr Neonatol; 2013 Aug; 54(4):239-45. PubMed ID: 23597528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
    Kupryś-Lipińska I; Tworek D; Vanderbist F; Bocheńska-Marciniak M; Kuna P
    Pneumonol Alergol Pol; 2013; 81(6):527-36. PubMed ID: 24142782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in pediatric aerosol delivery: importance of facemask.
    Smaldone GC; Berg E; Nikander K
    J Aerosol Med; 2005; 18(3):354-63. PubMed ID: 16181009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of relationship between peak inspiratory flow rate and amount of drug delivered to lungs following inhalation of fluticasone propionate with a Diskhaler.
    Yokoyama H; Yamamura Y; Ozeki T; Iga T; Yamada Y
    Biol Pharm Bull; 2007 Jan; 30(1):162-4. PubMed ID: 17202678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of a One-Dimensional Computational Model for the Prediction of Deposition from a Dry Powder Inhaler.
    Gourgoulianis K; Daniil Z; Athanasiou K; Rozou S; Bontozoglou V
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):435-443. PubMed ID: 28683222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.